Acquired by Agilent Technologies.
Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.
Acquired by Agilent Technologies.
THERAtRAME develops and positions new therapeutics targeting tRNA epitranscriptomics in cancer.
Helping clinicians make faster, smarter decisions with AI-powered alerts for patient deterioration.
Axithra is developing new technology for accurate drug concentrations in blood.
